Cookies are used on this website.
Cookies are used to provide social networking features and analyze traffic. We also share information about your use of our site with our social media, advertising, and analytics partners, who may combine it with other information you've given them or information they've gathered through your use of other services.
Early exacerbation detection for CHF (Congestive Heart Failure) & COPD chronic patients using AI and Infrasound
Our Mission is to significantly improve the quality of life of home hospitalized chronic patient with an effective and professional tool for early warning of clinical deterioration that will advance the treatment provided by the insurers and reduce the cost for the healthcare system.
The Sanolla promise
Early Detection & Monitoring, at Home
An intuitive self assessment and monitoring device, the PyXy provides
patients with a piece of mind and a positive life impact from the comfort
of their own home, by providing indication of the clinical condition on
the device display based on AI technology. Ideally suited for:
- Families with young children Elderly people
- Immobilized, quarantined or patients suffering from chronic
diseases
Highlights
Smart monitoring device with
real time feedback and multi
mode functionality (fully
embedded processor)
Infrasound based
analysis
Pulmonary and Cardiac
diseases
Superior sound
quality: device
and remote user
Patient specific – remote
update and communication
(Smartphone App,
cloud services)
Continuous Deep
Machine Learning
exacerbation detection
Independent
communication
platform (eSIM)
Our Technology
The Sound of Ingenuity
Infrasound
Expanded auscultation
sensory range presenting
novel data with potentially
unparalleled clinical value
Delivering crucial medical information by analyzing the body’s full spectrum of sounds including the invaluable infrasound range
Making Infrasound Accessible
- Our body produces infrasound – undetectable to the human ear
- Infrasound contains clinically significant data
- As of now, this vital information was not available
- By using frequency shifting algorithms we convert infrasound into audible range
- Presenting the full body sound spectrum in a proprietary sound signature
Improving patient care with cutting-edge devices
SaaS – On Unit Embedded AI
- Full-spectrum based AI disease classifiers
- Detects patient’s condition based on sounds resonating from the chest area
- Allows self-assessment and self-monitoring to identify improvement or exacerbation
- Does not require web connectivity for integration
About us
Founded in 2016 by a team of visionary industry experts with a mission of enhancing primary care, for health care professionals and patients, Sanolla leads the world’s first AI based infrasound auscultation technology.Capturig and analyzing the body’s full spectrum of sounds providing critical medical data at reduced costs while notably improving patients’ lives. The company has 3 product lines with promising clinical results, is ISO 13485 certified, FDA cleared, with several technology patents and it operates in the multibillion-dollar primary care diagnostic devices market.
Management Team
Founder & CEO
Olympus US - CTO
Olympus Israel - CEO
Cbyond - Founder & CEO
(Sold to Olympus)
Given Imaging - VP R&D
Business Development
Sabar Health - Home Hospital
Vice Chairman
Amal Group - Senior VP
HMC - VP BD & Marketing
Rabin Medical Center
Head - Medical Services
VP R&D
Olympus Israel Senior Manager - Software
Elbit
Senior Software Engineer
CMO
Tel-Aviv Sourasky MC
Director of Cardiology Division
Tel Aviv University Professor of Cardiology
Neovasc - Founder & CMO
Board of Directors
Chairman
Lumenis –
EVP & GM Lumenis Vision
Galil Medical –
Co. Founder & GM Galil Inc.
Rafael – Anti Armor BU
BD & Strategic Planning
Founder
Olympus US - CTO
Olympus Israel - CEO
Cbyond - Founder & CEO
(Sold to Olympus)
Given Imaging - VP R&D
Director
IHCV –
Managing Partner
Harel Insurance & Finance
Head of Claims Dep.
Director
Sabar Health
Chairman & President
Herzliya Medical Center - CEO
Clalit Health – HMO
CMO – Tel-Aviv District
Director
Next Leap Ventures
Partner
Adobe
VP Strategy & BD
Intel
Head of Strategic Planing
Director
Elie Balas has been the Chairman of the Board and Director of Business Development for Menchie's since 2008.
In addition to his duties with Menchie's, Elie serves as the Executive Director of Ami Adini & Associates, Inc., an environmental consulting company.
Partners
The Sound of Partnerships